日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor

多层分子谱分析为促纤维增生性小圆细胞肿瘤的诊断和靶向治疗提供信息

Renner, Marcus; Oleś, Małgorzata; Paramasivam, Nagarajan; Heilig, Christoph E; Schneider, Annika; Modugno, Caroline; Herremans, Catherine; Hüllein, Jennifer; Hutter, Barbara; Erkut, Cihan; Mock, Andreas; Krieghoff-Henning, Eva; Jensen, Cecilia B; Sakhteman, Amirhossein; The, Matthew; Prinz, Tony; Lajer, Panna; Baude-Müller, Annika; Beck, Katja; Beuthien-Baumann, Bettina; Apostolidis, Leonidas; Bauer, Sebastian; Boerries, Melanie; Brandts, Christian H; Rieke, Damian T; Kindler, Thomas; Klauschen, Frederick; Schulze-Osthoff, Klaus; Schlenk, Richard F; Berchem, Guy; Allgäuer, Michael; Mechtersheimer, Gunhild; Stenzinger, Albrecht; Lipka, Daniel B; Schlesner, Matthias; Kuster, Bernhard; Jahn, Arne; Schröck, Evelin; Heining, Christoph; Teleanu, Maria-Veronica; Horak, Peter; Kreutzfeldt, Simon; Hübschmann, Daniel; Hartmann, Wolfgang; Glimm, Hanno; Fröhling, Stefan

All patients with AML and FLT3-ITD should be transplanted in first remission. Also in the era of tyrosine kinase inhibitors? - the PRO

所有患有FLT3-ITD突变的急性髓系白血病(AML)患者都应在首次缓解期接受移植。即使在酪氨酸激酶抑制剂时代也是如此吗?——PRO

Kayser, Sabine; Schlenk, Richard F

Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial"

更正:“在QuANTUM-First试验中,造血细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响”

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience

在转移性乳腺癌中实现精准肿瘤治疗:全面基因组分析的临床影响——CATCH 经验

Hlevnjak, Mario; Heublein, Sabine; Thewes, Verena; Wagener, Lukas; Pixberg, Constantin; Fremd, Carlo; Michel, Laura; Maurer, Christian; Buschhorn, Lars; Dikow, Nicola; Feng, Fangyoumin; Fröhling, Stefan; Herold-Mende, Christel; Hirsch, Steffen; Hong, Chen; Hübschmann, Daniel; Jassowicz, Lena; Kozyulina, Polina; Pfütze, Katrin; Schlenk, Richard F; Sinn, Hans-Peter; Smetanay, Katharina; Springfeld, Christoph; Stenzinger, Albrecht; Wagner, Celina; Wolf, Stephan; Trumpp, Andreas; Jäger, Dirk; Zivanovic, Oliver; Zapatka, Marc; Schneeweiss, Andreas; Lichter, Peter

Construction of an Adverse Outcome Pathway Framework for Glyphosate-Induced Female Reproductive Toxicity Based on Toxicity Pathways

基于毒性通路构建草甘膦诱导女性生殖毒性不良结局通路框架

Peng, Bixia; Schlenk, Daniel; Liu, Jing

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial

CDK4/6抑制剂治疗晚期脊索瘤:NCT PMO-1601试验的最终结果

Teleanu, M-V; Heilig, C E; Pirmann, S; Hamacher, R; Bauer, S; Gaidzik, V I; Mayer-Steinacker, R; Al-Sabah, J; Roldan Pinzon, S S L; Süße, H; Freitag, A; Horak, P; Kreutzfeldt, S; Hutter, B; Hüllein, J; Sedlaczek, O; Lehner, B; Egerer, G; Jäger, D; Müller-Tidow, C; Hübschmann, D; von Kalle, C; Barth, T F E; Fröhling, S; Schlenk, R F

Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial

在QuANTUM-First试验中,造血干细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žak, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Herve; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

Proceeding Abstracts (Invitation Only)

会议摘要(仅限受邀者)

Kayser, Sabine; Sanber, Khaled; Marconi, Giovanni; Mattei, Agnese; Luskin, Marlise R; Kelkar, Amar; Cerrano, Marco; Kristensen, Daniel Tuyet; Roug, Anne Stidsholt; Sartor, Chiara; Giglio, Fabio; Riva, Marta; Rizzo, Lorenzo; Saraceni, Francesco; Guerzoni, Selene; Lessi, Federica; Borlenghi, Erika; Levis, Mark J; Schlenk, Richard F; Jain, Tania; Papayannidis, Cristina

Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine

TP53突变状态对老年AML患者在接受地西他滨治疗时加用全反式维甲酸或丙戊酸的影响

Bresser, Helena; Schmoor, Claudia; Grishina, Olga; Pfeifer, Dietmar; Thomas, Johanna; Rehman, Usama-Ur; Crysandt, Martina; Jost, Edgar; Thol, Felicitas; Heuser, Michael; Götze, Katharina S; Schlenk, Richard F; Salih, Helmut R; Schittenhelm, Marcus M; Heil, Gerhard; Schwaenen, Carsten; Müller-Tidow, Carsten; Brugger, Wolfram; Kündgen, Andrea; de Wit, Maike; Giagounidis, Aristoteles; Scholl, Sebastian; Neubauer, Andreas; Krauter, Jürgen; Bug, Gesine; May, Annette M; Wäsch, Ralph; Duyster, Justus; Döhner, Konstanze; Ganser, Arnold; Döhner, Hartmut; Hackanson, Björn; Becker, Heiko; Lübbert, Michael

COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II Study

认知指南——基因组学指导的早期乳腺癌患者新辅助后靶向治疗:一项多中心、开放标签、伞式II期研究的研究设计

Pixberg, Constantin; Maurer, Christian; Smetanay, Katharina; Straßl, Luise; Hlevnjak, Mario; Zapatka, Marc; Wagner, Celina V; Yazdanparast, Haniyeh; Kurzawa, Johanna; Erben, Vanessa; Feng, Fangyoumin; Hong, Chen; Hübschmann, Daniel; Buschhorn, Lars; Suppelna, Jan Philip; Michel, Laura; Heublein, Sabine; Fremd, Carlo; Zivanovic, Oliver; Sinn, Peter; Stenzinger, Albrecht; Haidinger, Renate; Schumacher-Wulf, Eva; Ditsch, Nina; Loibl, Sibylle; Fröhling, Stefan; Link, Theresa; Wimberger, Pauline; Blohmer, Jens-Uwe; Huebner, Hanna; Fasching, Peter A; Janni, Wolfgang; Schlenk, Richard F; Thewes, Verena; Lichter, Peter; Schneeweiss, Andreas